Beyond Eczema: How the Skin Microbiome Connects Atopic Dermatitis, Seborrheic Dermatitis, Acne, and Rosacea

Most people think about their skin condition as a single, isolated diagnosis. Eczema. Acne. Rosacea. Seborrheic dermatitis. Each treated separately, each with its own product category, its own dermatology visit, its own internet rabbit hole. But the research of the last few years — and particularly a landmark 2026 review — is telling a different story. These conditions are not isolated. They share a common underlying axis involving sebum, the skin microbiome, inflammation, and barrier function. The specific organisms are different. The location on the face and body is different. The dominant inflammatory pathway is different. But the framework is the same. And understanding that framework changes how you think about caring for any of them.

TL;DR

• Atopic dermatitis, seborrheic dermatitis, acne, and rosacea are distinct conditions — but they share a common underlying axis involving the skin microbiome, sebum, inflammation, and barrier dysfunction
• A 2026 review in Dermato proposed that acne and rosacea arise from “partially overlapping perturbations along a shared sebum-microbiome-inflammation-barrier axis” — a framework that extends to all four conditions
• Each condition is driven by a different microbiome imbalance: S. aureus in atopic dermatitis, Malassezia in seborrheic dermatitis, Cutibacterium acnes in acne, and bacterial dysbiosis including Demodex in rosacea
• The gut-skin axis connects all four — gut microbiome dysbiosis amplifies skin inflammation across conditions
• A microbiome-supportive skincare approach addresses the shared underlying axis rather than suppressing individual symptoms — relevant across all four conditions
• The Bi-Om Complex™ targets the specific organisms most relevant to atopic dermatitis and seborrheic dermatitis, while its anti-inflammatory mechanisms are relevant to acne and rosacea as well
• National Healthy Skin Month is a good reminder that skin health is a system — not a collection of separate conditions to be treated in isolation

In This Article

1. What Is the Shared Axis Connecting These Conditions?
2. Atopic Dermatitis and the Microbiome
3. Seborrheic Dermatitis and the Microbiome
4. Acne and the Microbiome
5. Rosacea and the Microbiome
6. The Gut-Skin Axis: The Connection Beneath the Surface
7. What a Microbiome-Supportive Approach Means Across Conditions
8. FAQs About the Skin Microbiome and Inflammatory Skin Conditions

What Is the Shared Axis Connecting These Conditions?

A 2026 review published in Dermato proposed a framework that reframes how we understand inflammatory facial skin conditions. Acne and rosacea are distinct clinical entities arising from partially overlapping but differentially weighted perturbations along a shared sebum-microbiome-inflammation-barrier axis. The same framework extends to atopic dermatitis and seborrheic dermatitis.

The axis works like this:

Sebum — the skin’s natural oil, produced by sebaceous glands in the dermis — is both a barrier component and a food source for certain microorganisms. When sebum composition or production changes, the microbial balance shifts.

The microbiome — the community of bacteria, fungi, and other microorganisms on the skin’s surface — responds to those sebum changes, to environmental triggers, to hormonal shifts, and to the skin’s immune state. When it becomes dysbiotic — meaning specific organisms overgrow or beneficial diversity collapses — it drives inflammation.

Inflammation — the immune system’s response to dysbiosis and barrier compromise — is the common visible feature of all four conditions. But the inflammatory pathway is different for each: Th2 in atopic dermatitis, innate immune activation in acne, neurovascular dysregulation in rosacea.

Barrier dysfunction — the structural compromise that makes all four conditions harder to manage — both contributes to and results from the dysbiosis and inflammation. A permeable barrier allows more triggers to reach the immune system. More immune activation further damages the barrier.

Understanding this shared axis explains why the same person can have more than one of these conditions simultaneously — and why conditions that look very different on the surface share surprisingly similar management principles.

Learn more: What Is Eczema? The Complete Guide

Atopic Dermatitis and the Microbiome

Atopic dermatitis is the most extensively studied of the four conditions from a microbiome perspective. The mechanism is well-established: S. aureus colonizes up to 90% of eczema-prone skin during flares — producing toxins that directly damage barrier proteins, trigger the Th2 immune overreaction characteristic of atopic dermatitis, and amplify the itch-scratch cycle. Microbial diversity collapses as S. aureus dominates.

What makes atopic dermatitis distinct within the shared axis is the primacy of the immune component. The Th2 skew is the dominant driver — S. aureus dysbiosis and barrier dysfunction both amplify and are amplified by it, but the immune predisposition is what makes skin atopic in the first place.

Learn more: Atopic Dermatitis vs Seborrheic Dermatitis
Learn more: 7 Types of Eczema: Microbiome Guide

Seborrheic Dermatitis and the Microbiome

Seborrheic dermatitis sits at the fungal end of the microbiome-skin axis. Malassezia — a yeast that is a normal part of the skin’s microflora — proliferates beyond its normal range in sebum-rich areas. As it metabolizes the fatty acids in sebum, it produces inflammatory byproducts that drive the redness and flaking characteristic of the condition.

Research comparing the facial microbiome of seborrheic dermatitis and rosacea patients found a key distinction: seborrheic dermatitis involves imbalanced fungal and bacterial communities, whereas rosacea is more likely to be related to dysbiosis of solely the bacterial community. The Malassezia component is what makes seborrheic dermatitis unique within the axis — and what makes formula texture so important in its management. Heavy oils that feed Malassezia worsen the condition regardless of what other active ingredients are present.

Learn more: Atopic Dermatitis vs Seborrheic Dermatitis

Acne and the Microbiome

Acne has long been associated with Cutibacterium acnes — formerly called Propionibacterium acnes — but the microbiome story is more nuanced than “too much C. acnes causes acne.” Research now shows that it’s not the abundance of C. acnes but the diversity of its strains that matters. Certain strains are pro-inflammatory; others are actually protective. A dysbiotic shift toward pro-inflammatory strains — combined with sebum overproduction and follicular hyperkeratosis — is what drives acne development.

The 2026 Dermato review is particularly useful here: acne is centered on the follicular unit and early innate immune activation triggered by microbial and lipid-derived stimuli — a mechanism distinct from the Th2 pathway of atopic dermatitis but equally microbiome-dependent.

For acne-prone skin that is also sensitive or eczema-prone — a common combination — this matters because the management approaches need to address both the follicular dysbiosis driving acne and the barrier compromise and S. aureus dynamics driving eczema, without the harsh actives (benzoyl peroxide, high-strength retinoids) that can worsen barrier function in atopic skin.

Rosacea and the Microbiome

Rosacea is the most complex of the four conditions from a microbiome perspective — and the one where the research is still most actively evolving. Rosacea patients consistently exhibit microbial dysbiosis characterized by increased pro-inflammatory taxa including Staphylococcus epidermidis, Corynebacterium, and Streptococcus. Unlike atopic dermatitis — where the dominant organism is well-characterized — rosacea dysbiosis involves multiple bacterial shifts rather than a single dominant pathogen.

Rosacea also involves Demodex mites — naturally present on all human skin but overgrown in rosacea — and a neurovascular component that distinguishes it from the other three conditions. The flushing, persistent redness, and visible blood vessels of rosacea reflect dysregulation in how the skin’s vascular and nervous systems respond to triggers — amplified by microbial dysbiosis and barrier fragility.

A 2026 systematic review confirmed growing evidence linking skin microbiome composition to rosacea development and severity — through changes in bacterial composition, interactions with the immune system, and induction of inflammation — while noting that therapeutic implications remain an active area of research.

For people with both rosacea and eczema-prone skin — a combination that is more common than most people realize — understanding the distinct microbiome mechanisms of each helps explain why a single product rarely addresses both adequately.

The Gut-Skin Axis: The Connection Beneath the Surface

One thread that runs through all four conditions is the gut-skin axis — the relationship between gut microbiome health and skin microbiome balance. A systematic review confirmed that dysbiosis is increasingly recognized across inflammatory skin diseases including atopic dermatitis, psoriasis, acne, and rosacea — connected through the gut-skin axis via complex immunological and neuroendocrine mechanisms.

In practical terms, this means that gut microbiome disruption — from antibiotics, poor diet, chronic stress, or illness — can amplify skin inflammation across all four conditions simultaneously. And conversely, supporting gut microbiome health through diet, fermented foods, and reduced inflammatory load can have measurable benefits for skin across multiple conditions.

This is why the foods and lifestyle recommendations of Korean medicine — fermented foods like kimchi, warming foods that support the spleen and digestive function, HIIT-level movement for circulation — have relevance not just for eczema but for all four conditions. Korean medicine understood the body as a system long before the gut-skin axis had a name.

Learn more: Prebiotics, Probiotics and Postbiotics in Skincare

What a Microbiome-Supportive Approach Means Across Conditions

The shared axis framework suggests that a microbiome-supportive approach has relevance beyond eczema — and that the same principles apply across all four conditions, adjusted for the specific organism driving each one.

For atopic dermatitis — target S. aureus specifically while supporting beneficial bacterial diversity. Barrier repair is foundational. Learn more: Steroid-Free Eczema Treatment

For seborrheic dermatitis — target Malassezia through antifungal botanical activity and yeast-safe lipids. Avoid heavy oils. Formula texture matters as much as active ingredients.

For acne-prone skin — support balanced C. acnes strains rather than eliminating C. acnes entirely. Avoid harsh actives that disrupt the barrier and trigger compensatory sebum overproduction.

For rosacea — reduce pro-inflammatory bacterial load while supporting barrier integrity and avoiding triggers that activate the neurovascular component.

The Calm & Restore Duo was formulated specifically for atopic and seborrheic dermatitis — the ABC Microbiome Calming Lotion and R+R Barrier Recovery Mist address both S. aureus and Malassezia through the Bi-Om Complex™, in a lightweight formula built around squalane — a yeast-safe lipid that provides barrier support without feeding Malassezia.

The ABC Lotion also contains the AI Amino-Peptide Complex™ — Copper Tripeptide-1 alongside amino acids that support the skin’s Natural Moisturizing Factor. Copper Tripeptide-1 specifically has documented anti-inflammatory properties relevant to rosacea and reactive inflammatory skin conditions, suppressing pro-inflammatory cytokines through gene expression modulation. For conditions like rosacea where barrier fragility and chronic low-grade inflammation are central, this regenerative support complements the microbiome-targeted approach of the Bi-Om Complex™.

The R+R Mist adds Lactobacillus Ferment postbiotic and Hedera Helix extract — the latter contributing anti-inflammatory activity through IL-6 inhibition and antifungal properties through its saponin content, relevant across seborrheic and inflammatory skin conditions.

FAQs About the Skin Microbiome and Inflammatory Skin Conditions

Skin as a System

National Healthy Skin Month is built around the idea that healthy skin requires consistent, proactive care — not just reactive treatment when something goes wrong. The shared axis connecting eczema, seborrheic dermatitis, acne, and rosacea is the scientific argument for why that proactive framework makes sense. These conditions share underlying drivers. Addressing those drivers — microbiome health, barrier function, inflammatory signaling — is what produces the kind of skin stability that makes individual conditions easier to manage.

The Calm & Restore Duo is designed around exactly this framework. Lightweight enough for oily and combination skin. Microbiome-supportive for atopic and seborrheic conditions. Barrier-first for eczema-prone skin. The ABC Lotion’s AI Amino-Peptide Complex™ — Copper Tripeptide-1 and NMF amino acids — adds a regenerative layer relevant to rosacea and reactive inflammatory skin. The R+R Mist’s Lactobacillus Ferment and Hedera Helix round out the microbiome and anti-inflammatory support. A daily foundation that works with the skin’s own systems.